Yes, Empahert - 25 (Empagliflozin 10mg/25mg Tablets) may provide several long-term benefits for people with type 2 diabetes when used as prescribed alongside diet and exercise. By inhibiting SGLT-2 in the kidneys, it helps maintain better blood sugar control by increasing the excretion of excess glucose through urine. Over time, consistent blood sugar management can help reduce the risk of diabetes-related complications. Additionally, Empahert -25 has been shown to reduce the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease, making it a valuable option for long-term diabetes care. Patients should continue regular medical follow-ups to monitor their overall health and treatment progress.